ImmunityBio converts from Immunomedics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ImmunityBio converts from Immunomedics

An SI Board Since February 2023

Posts	SubjectMarks	Bans	Symbol
1518	51	0	IBRX

Emcee: TinfoilHat	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1017	Avoro Capital.. Google them or go to their website. They invest in biotech solu	galt	1	5/7/2025
1016	Avoro?	CCS648	-	5/7/2025
1015	Like many here have said, this is acting very much like IMMU and has given many	galt	5	5/7/2025
1014	de-ja vu...........reminds me of the time idahoranch talked of adding under 2$ I	urslor	3	5/7/2025
1013	This is going to be the confirmatory trail for NSCLC. It recently updated to rec	mannamal	3	5/6/2025
1012	clinicaltrials.gov	mannamal	3	5/6/2025
1011	Press releases are typically drafted by Comms or Marketing departments and roll	TinfoilHat	3	5/6/2025
1010	My only quibble with your observation of the perhaps intentional obfuscation via	jargonweary	-	5/6/2025
1009	Having held IMMU for many years and endured similar disappointments I would just	jargonweary	7	5/6/2025
1008	The press release reads to me like a CYA from management/PSS to the new investor	Maturin	2	5/6/2025
1007	I did not hold IMMU, but I’ve seen so many references - it has given me a little	CCS648	1	5/6/2025
1006	"But if that’s your perception of the intent (obfuscation), why are you an	Fitzhughlaw	4	5/6/2025
1005	Happily, I did not do corporate defense work, nor is that the focus of my positi	CCS648	-	5/6/2025
1004	"[T]he 8-k response does not read to me like it was written by a lawyer.&qu	Fitzhughlaw	3	5/6/2025
1003	Or possibly the people who led IBRX officials to believe that the application wo	CCS648	3	5/6/2025
1002	I know you’re a lawyer, as was I (judge now), and thus pay close attention to wo	CCS648	-	5/6/2025
1001	Picked up another 7k shares this morning so hopefully we get clarity soon...	erippetoe	-	5/6/2025
1000	I am prepared to believe that the FDA encouraged them to file and, if true, that	jargonweary	4	5/6/2025
999	So upon further review of the company's PR, I need to amend my prior absolut	Fitzhughlaw	4	5/6/2025
998	"[S]ome institutions exit and others are clearly uninterested. Why? Perhaps	Fitzhughlaw	8	5/5/2025
997	Sounds eerlily familiar, as in IMMU, except that IBRX already has one approved i	galt	1	5/5/2025
996	This is dated, but informative just the same: fda.gov	mannamal	-	5/5/2025
995	I am not adding more at this point because a) I already have too much and, b) I	jargonweary	1	5/5/2025
994	Unfortunately, this could lead to another class action suit. Just saying, but ho	galt	3	5/5/2025
993	Obviously the company was working their response all weekend long given they rec	Maturin	-	5/5/2025

Go to reply# or date (mm/dd/yy):